Advertisement

Topics

ImmusanT Inc. Company Profile

12:31 EDT 20th September 2018 | BioPortfolio

ImmusanT is a privately-held biotechnology company focused on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that aim to improve diagnosis and treatment and return patients to a normal diet, good health and improved quality of life. The company is developing Nexvax2®, a therapeutic vaccine for celiac disease, and a companion diagnostic and monitoring tool to improve celiac disease management. ImmusanT’s targeted immunotherapy discovery platform can be applied to a variety of epitope-specific autoimmune diseases. Founded in 2010, ImmusanT is backed by Vatera Healthcare Partners. More information may be found at www.ImmusanT.com, or follow ImmusanT on Twitter.


News Articles [8 Associated News Articles listed on BioPortfolio]

Daiichi Sankyo’s Ken Truitt Joins ImmusanT as Chief Medical Officer

Ken Truitt has been appointed chief medical officer of immune drug developer ImmusanT. Truitt comes to the Cambridge, MA, biotech from Daiichi Sankyo, where he was senior vice president for internal m...

#news #biotech ImmusanT goes on hiring spree ahead of phase 2 celiac vaccine trial

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: ImmusanT goes on hiring spree ahead of phase 2 celiac vaccine trial .ImmusanT...

ImmusanT receives JDRF T1D Fund to develop novel vaccine candidate for type 1 diabetes

ImmusanT, Inc., a clinical stage company that is leveraging its Epitope-Specific Immuno-Therapy™ platform to translate and deliver first-in-class peptide-based immune therapies to people living with...

ImmusanT CEO Leslie Williams to Discuss Immunology of Celiac Disease at 2018 BIO International Convention

-- ImmusanT will also provide a corporate update -- ImmusanT, Inc., a clinical stage company that is leveraging its Epitope-Specific Immuno-Therapy (ESIT) platform to t...

ImmusanT Expands Platform to Type 1 Diabetes with Investment from JDRF T1D Fund

ImmusanT, Inc., a clinical stage company that is leveraging its Epitope-Specific Immuno-Therapy™ (ESIT™) platform to translate and deliver first-in-class peptide-based ...

ImmusanT Welcomes Ken Truitt, M.D. as Chief Medical Officer

ImmusanT, Inc., a clinical stage company that is leveraging its Epitope-Specific Immuno-Therapy (ESIT) platform to translate and deliver first-in-class peptide-based immune...

ImmusanT Expands Management Team to Strengthen Financial Operations and Accelerate Clinical Development

-- Kristin M. Neff joins as VP, Clinical Operations and Project Management – -- Joyce A. Pinkham joins as VP, Program Management – -- Jonathan Yeadon ...

ImmusanT Adds Robert J. Perez to Board of Directors

-- Joins representatives from investors ARCH Venture Partners and Vatera Holdings LLC -- ImmusanT, Inc., a clinical stage company that is leveraging its Epitope-...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

ImmusanT Inc.

ImmusanT is a privately-held biotechnology company focused on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that aim to improve diagn...

ImmusanT, Inc.

ImmusanT is a privately held biotechnology company focused on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that aim to improve diagn...

More Information about "ImmusanT Inc." on BioPortfolio

We have published hundreds of ImmusanT Inc. news stories on BioPortfolio along with dozens of ImmusanT Inc. Clinical Trials and PubMed Articles about ImmusanT Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ImmusanT Inc. Companies in our database. You can also find out about relevant ImmusanT Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...


Corporate Database Quicklinks



Searches Linking to this Company Record